Na Ri Yoon, Young Jin Na, Jong Hwan Lee, Inmyung Song, Eui-Kyung Lee, Mi-Hai Park. Evaluation of changes in the clinical benefits of oncology drugs over time following reimbursement using the ASCO-VF and the ESMO-MCBS. J Cancer Res Clin Oncol. 2024 Mar 4;150(3):113.
Yong Hwa Lee, Dasom An, Youngsuk Baek, Kyungsook Yoo, Sumi Hyun, Sun-Kyeong Park, Eui-Kyung Lee. Factors Influencing Drug Shortages and Their Resolution in South Korean Community Pharmacies. Risk Management and Healthcare Policy. 2024; 17:2083–2095.
Byun JY, Aiyeolemi A, Qdaisat A, Park C. Association between epidermal growth factor receptor-tyrosine kinase inhibitors and venous thromboembolism among older patients with advanced non-small cell lung cancer. Cancer. 2024 Jun 7.
Jung HI, Kwon SH, Nam JH, Cho JY, Lee EK. Real-world effectiveness of CDK4/6 inhibitors on patients with HR+/HER2- advanced breast cancer in South Korea, focusing on underrepresented patients. Curr Med Res Opin. 2024 May 9:1-9.
Shim YB, Byun JY, Lee JY, Lee EK, Park MH. Economic burden of brain metastases in non-small cell lung cancer patients in South Korea: A retrospective cohort study using nationwide claims data. PLoS One. 2022 Sep 20;17(9):e0274876
Yang SY, Kang DW, Nam JH, Choi EK, Lee EK, Shin JY, Kwon SH. Adherence is an optimal factor for maximizing the effective and safe use of oral anticoagulants in patients with atrial fibrillation. Sci Rep. 2022 Mar 1;12(1):3413.
Ha SY, Kang DW, Jung HI, Lee EK, Park MH. Value-Based Pricing and Budget Impact Analysis for Multi-Indication Drugs: A Case Study of Immunotherapies. Int J Environ Res Public Health. 2022 Mar 30;19(7):4105.
Kang, D. W., Shim, Y. B., Lee, E. K., & Park, M. H. (2022). Healthcare resource utilization and medical costs in patients with terminal cancer during best supportive care. PloS one, 17(6), e0269565.
논문 보기(doi) : 10.1371/journal.pone.0269565. eCollection 2022
Jang SC, Kwon SH, Min S, Jo AR, Lee EK, Nam JH. Optimal Indicator of Death for Using Real-World Cancer Patients' Data From the Healthcare System. Front Pharmacol. 2022
Jang, S. C., Nam, J. H., Lee, S. A., An, D., Kim, H. L., Kwon, S. H., & Lee, E. K. (2022). Clinical manifestation, economic burden, and mortality in patients with transthyretin cardiac amyloidosis. Orphanet Journal of Rare Diseases, 17(1), 1-10.
Na Ri Yoon, Young Jin Na, Jong Hwan Lee, Inmyung Song, Eui-Kyung Lee, Mi-Hai Park. Evaluation of changes in the clinical benefits of oncology drugs over time following reimbursement using the ASCO-VF and the ESMO-MCBS. J Cancer Res Clin Oncol. 2024 Mar 4;150(3):113.
논문보기(doi) : https://doi.org/10.1007/s00432-023-05587-0
Yong Hwa Lee, Dasom An, Youngsuk Baek, Kyungsook Yoo, Sumi Hyun, Sun-Kyeong Park, Eui-Kyung Lee. Factors Influencing Drug Shortages and Their Resolution in South Korean Community Pharmacies. Risk Management and Healthcare Policy. 2024; 17:2083–2095.
논문보기(doi) : https://doi.org/10.2147/rmhp.s473859
Byun JY, Aiyeolemi A, Qdaisat A, Park C. Association between epidermal growth factor receptor-tyrosine kinase inhibitors and venous thromboembolism among older patients with advanced non-small cell lung cancer. Cancer. 2024 Jun 7.
논문보기(doi) : https://doi.org/10.1002/cncr.35424
Jung HI, Kwon SH, Nam JH, Cho JY, Lee EK. Real-world effectiveness of CDK4/6 inhibitors on patients with HR+/HER2- advanced breast cancer in South Korea, focusing on underrepresented patients. Curr Med Res Opin. 2024 May 9:1-9.
논문보기(doi) : https://doi.org/10.1080/03007995.2024.2349741
Shim YB, Byun JY, Lee JY, Lee EK, Park MH. Economic burden of brain metastases in non-small cell lung cancer patients in South Korea: A retrospective cohort study using nationwide claims data. PLoS One. 2022 Sep 20;17(9):e0274876
논문 보기(doi) : 10.1371/journal.pone.0274876
Yang SY, Kang DW, Nam JH, Choi EK, Lee EK, Shin JY, Kwon SH. Adherence is an optimal factor for maximizing the effective and safe use of oral anticoagulants in patients with atrial fibrillation. Sci Rep. 2022 Mar 1;12(1):3413.
논문 보기(doi) : 10.1038/s41598-022-07316-y
Ha SY, Kang DW, Jung HI, Lee EK, Park MH. Value-Based Pricing and Budget Impact Analysis for Multi-Indication Drugs: A Case Study of Immunotherapies. Int J Environ Res Public Health. 2022 Mar 30;19(7):4105.
논문 보기(doi) : 10.3390/ijerph19074105
Kang, D. W., Shim, Y. B., Lee, E. K., & Park, M. H. (2022). Healthcare resource utilization and medical costs in patients with terminal cancer during best supportive care. PloS one, 17(6), e0269565.
논문 보기(doi) : 10.1371/journal.pone.0269565. eCollection 2022
Jang SC, Kwon SH, Min S, Jo AR, Lee EK, Nam JH. Optimal Indicator of Death for Using Real-World Cancer Patients' Data From the Healthcare System. Front Pharmacol. 2022
논문 보기(doi) : 10.3389/fphar.2022.906211
Jang, S. C., Nam, J. H., Lee, S. A., An, D., Kim, H. L., Kwon, S. H., & Lee, E. K. (2022). Clinical manifestation, economic burden, and mortality in patients with transthyretin cardiac amyloidosis. Orphanet Journal of Rare Diseases, 17(1), 1-10.
논문 보기(doi) : 10.1186/s13023-022-02425-3